
|Articles|February 1, 2019
- Pharmaceutical Executive-02-01-2019
- Volume 39
- Issue 2
Pharmaceutical Executive, February 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Q&A: Regulatory Reform in Chinaalmost 7 years ago
China: A Change in Attitudealmost 7 years ago
New Roads to Chinaalmost 7 years ago
Closing the Pharma and Digital Health Dividealmost 7 years ago
A Leading Man’s Next Actalmost 7 years ago
Two Steps Forwardalmost 7 years ago
Let the Drug Pricing Games Beginalmost 7 years ago
Mixed Outlook for China Life Sciencesalmost 7 years ago
CFIUS Reform’s Impact on Biopharmaabout 7 years ago
Op-Ed: Opening the Golden DoorNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
3
FDA Announces New Domestic-Manufacturing-Focused Pilot Program
4
Pharmaceutical Executive Daily: FDA Reveals PreCheck Pilot Program
5




